Darby Private Equity, the private equity arm of Franklin Templeton Investments, invested in Biopas, a Latin American specialty pharmaceutical distribution company. No financial terms were disclosed. “We are excited to partner with Biopas, a leading pharmaceutical company that is focused on transforming the lives of patients in Latin America. This transaction aligns with Darby’s commitment to investing in Latin American companies with strong management and a successful track record,” commented Ignacio Aicardi, Managing Director at Darby.